BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19624875)

  • 1. [Impact of PrLZ overexpression on invasion of prostate cancer LNCaP cells in vitro].
    Zhang D; Li L; Zhang LL; Xue Y; Wang XY; He DL
    Ai Zheng; 2009 May; 28(5):483-6. PubMed ID: 19624875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrLZ expression is associated with the progression of prostate cancer LNCaP cells.
    Li L; Zhang D; Zhang L; Zhu G; Sun Y; Wu K; Wang X; He D
    Mol Carcinog; 2009 May; 48(5):432-40. PubMed ID: 18800346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrLZ is expressed in normal prostate development and in human prostate cancer progression.
    Wang R; Xu J; Mabjeesh N; Zhu G; Zhou J; Amin M; He D; Marshall FF; Zhau HE; Chung LW
    Clin Cancer Res; 2007 Oct; 13(20):6040-8. PubMed ID: 17947466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of PC-1 gene expression on migration ability of prostate cancer cells].
    Zhang H; Wan LC; Wang J; Zhou JG; Huang CF
    Ai Zheng; 2005 Sep; 24(9):1043-7. PubMed ID: 16159422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene.
    Gao L; Wu GJ; Liu XW; Zhang R; Yu L; Zhang G; Liu F; Yu CG; Yuan JL; Wang H; Yao LB
    Cancer Lett; 2011 Nov; 310(1):94-100. PubMed ID: 21741166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PC-1/PrLZ contributes to malignant progression in prostate cancer.
    Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG
    Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
    Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism.
    Villar J; Arenas MI; MacCarthy CM; Blánquez MJ; Tirado OM; Notario V
    Cancer Res; 2007 Nov; 67(22):10859-68. PubMed ID: 18006831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
    Ling YX; Tao J; Fang SF; Hui Z; Fang QR
    Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.
    Romanov VI; Durand DB; Petrenko VA
    Prostate; 2001 Jun; 47(4):239-51. PubMed ID: 11398171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor and invasion in prostate cancer.
    Hara T; Miyazaki H; Lee A; Tran CP; Reiter RE
    Cancer Res; 2008 Feb; 68(4):1128-35. PubMed ID: 18281488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer.
    Singh S; Sadacharan S; Su S; Belldegrun A; Persad S; Singh G
    Cancer Res; 2003 May; 63(9):2306-11. PubMed ID: 12727854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
    Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
    FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K; Uemura H; Ishiguro H; Kubota Y
    Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy.
    Zeng J; Liu W; Fan YZ; He DL; Li L
    Theranostics; 2018; 8(1):109-123. PubMed ID: 29290796
    [No Abstract]   [Full Text] [Related]  

  • 20. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
    Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
    Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.